Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities
Clinical trial NCT01906866 · COMPLETED
Trial details
- NCT number
- NCT01906866
- Sponsor
- Neurim Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2018-03-27
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.